Diagnostic News and Research

RSS

RayBiotech announces biomarker grant winners

RayBiotech, Inc. has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. Ray (Ruopan) Huang, Founder and President of RayBiotech, "we intend to demonstrate that any researcher with a modest research budget can successfully discover and validate disease-related biomarkers using our antibody arrays."

6 May 2010

LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

LightLab Imaging, Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for vascular and other imaging applications, has received clearance from the U.S. Food and Drug Administration (FDA) for the C7-XR Imaging System and companion C7 Dragonfly Imaging Catheter.

5 May 2010

Investment report on Misonix from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Misonix Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

5 May 2010

Genetics researchers use new approach to detect causal gene variants

In findings that may speed the search for disease-causing genes, a new study challenges the prevailing view that common diseases are usually caused by common gene variants (mutations). Instead, say genetics researchers, the culprits may be numerous rare variants, located in DNA sequences farther away from the original "hot spots" than scientists have been accustomed to look.

5 May 2010

Research analyzes clinical connection of NPH to AD

Normal Pressure Hydrocephalus is a neurological condition which typically affects adults ages 55 and older. This condition was first described in the 1960s as a triad of gait disturbance, dementia, and bladder incontinence. The ventricles of the brain appear enlarged although the cerebrospinal fluid pressure remains normal.

5 May 2010

CombiMatrix first-quarter diagnostic lab revenues up 29% sequentially

CombiMatrix Corporation today reported financial results for the three months ended March 31, 2010.

5 May 2010

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Myriad Genetics, Inc. today reported financial results for the third fiscal quarter and the nine-month period ended March 31, 2010.

5 May 2010

Biotech industry reviews effects of the recession

Minneapolis Star Tribune, on the Biotechnology Industry Organization's convention in Chicago: "The biotechnology industry, hurt by the recession, is looking for inspiration from Charles Darwin. Leading executives say unless biotech companies adapt to a less-robust economy and changing industry standards, they won't survive the downturn. Biotech start-ups, seen as the lifeblood of the industry, have been among the worst hit by a decline in venture capital investments."

5 May 2010

Techne declares dividend of $0.26 per share for quarter ended March 31, 2010

Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.26 per share for the quarter ended March 31, 2010. The quarterly dividend will be payable May 28, 2010 to all common shareholders of record on May 14, 2010. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

From BiosPacific, Inc. 4 May 2010

Approval of personalized therapy for lung cancer in Europe will change way of treatment

The recent approval of Europe's first personalized treatment for lung cancer heralds the arrival of a new era for lung cancer treatment that will demand significant changes to the way cancer specialists and other hospital doctors work, a leading expert said today at the 2nd European Lung Cancer Conference in Geneva, Switzerland.

4 May 2010

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Illumina, Inc. today announced that the U.S. Food and Drug Administration has granted 510(k) market clearance for the company's BeadXpress system for multiplex genetic analysis.

From Illumina, Inc. 4 May 2010

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.

4 May 2010

Novel biomarker test predicts risk of disease progression in patients with Crohn's disease

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings supporting a novel, algorithm-based biomarker test that helps clinicians effectively predict the risk of developing aggressive disease in patients with Crohn's disease.

4 May 2010

First of 5 Grand Challenges: Create point-of-care tools to diagnose range of illnesses

The Hon. James Flaherty, Minister of Finance for Canada, today announced the launch of Grand Challenges Canada, an innovative initiative that will help redefine Canada's role in the developing world by bringing together Canadian scientists, developing world scientific researchers, and the private sector to solve some of the most persistent health challenges facing poor countries.

4 May 2010

Drive for expediency should not compromise care in breast cancer diagnosis, treatment

While timely care can reduce stress among breast cancer patients about their condition, the drive for expediency should not compromise other factors important to care, such as safety, effectiveness, efficiency, and equity, according to new research findings published in the April issue of the Journal of the American College of Surgeons.

4 May 2010

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Lung researchers at Johns Hopkins have identified a possible protein trigger responsible for sarcoidosis, a potentially fatal inflammatory disease marked by tiny clumps of inflammatory cells that each year leave deep, grainy scars on the lungs, lymph nodes, skin and almost all major organs in hundreds of thousands of Americans.

4 May 2010

Study finds standard heel-stick test ineffective in identifying CMV infection in babies

A national study involving a UT Southwestern Medical Center neonatologist and pediatric infectious diseases specialist suggests that a screening test routinely performed in newborns is not very good at identifying cytomegalovirus (CMV) infection, a leading cause of hearing loss in children.

4 May 2010

New diagnostic tool could help detect heart attacks

A diagnostic tool developed by Rice University scientists to detect heart attacks using a person's saliva is being tested at the Michael E. DeBakey VA Medical Center in collaboration with Baylor College of Medicine in Houston.

4 May 2010

QIAGEN reports 20% revenue growth in first quarter 2010

QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.

From QIAGEN Manchester Limited 4 May 2010

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.

3 May 2010

Diagnostic News and Research

RayBiotech announces biomarker grant winners

LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

Investment report on Misonix from MicroStockProfit.com

Genetics researchers use new approach to detect causal gene variants

Research analyzes clinical connection of NPH to AD

CombiMatrix first-quarter diagnostic lab revenues up 29% sequentially

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Biotech industry reviews effects of the recession

Techne declares dividend of $0.26 per share for quarter ended March 31, 2010

Approval of personalized therapy for lung cancer in Europe will change way of treatment

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Novel biomarker test predicts risk of disease progression in patients with Crohn's disease

First of 5 Grand Challenges: Create point-of-care tools to diagnose range of illnesses

Drive for expediency should not compromise care in breast cancer diagnosis, treatment

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Study finds standard heel-stick test ineffective in identifying CMV infection in babies

New diagnostic tool could help detect heart attacks

QIAGEN reports 20% revenue growth in first quarter 2010

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News